Global Preclinical CRO Market Growth (Status and Outlook) 2023-2029

Global Preclinical CRO Market Growth (Status and Outlook) 2023-2029

A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.

LPI (LP Information)' newest research report, the “Preclinical CRO Industry Forecast” looks at past sales and reviews total world Preclinical CRO sales in 2022, providing a comprehensive analysis by region and market sector of projected Preclinical CRO sales for 2023 through 2029. With Preclinical CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical CRO industry.

This Insight Report provides a comprehensive analysis of the global Preclinical CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preclinical CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preclinical CRO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical CRO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical CRO.

The global Preclinical CRO market size is projected to grow from US$ 12730 million in 2022 to US$ 22660 million in 2029; it is expected to grow at a CAGR of 8.6% from 2023 to 2029.

Global core preclinical CRO players include Charles River, Wuxi AppTec, Labcorp and Eurofins Scientific etc. The top 5 companies hold a share about 50%. North America is the largest market, with a share about 45%, followed by Asia Pacific and Europe with the share about 32% and 15%. In terms of product, bioanalysis and DMPK studies is the largest segment, with a share about 45%, followed by toxicology testing, with a share about 20%. And in terms of application, the largest application is pharmaceutical companies, with a share about 80%, followed by medical device companies.

This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical CRO market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others

Segmentation by application
Pharmaceutical Companies
Medical Device Companies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON Plc
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology

Please note: The report will take approximately 2 business days to prepare and deliver.